Self-Injections Market Forecast Insights: The Road To $15.05 Billion By 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Self-Injections Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The self-injections market has experienced substantial growth in recent years. Its valuation is set to expand from $10.22 billion in 2025 to $11.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This historic market expansion is attributed to factors such as the increasing prevalence of chronic diseases, greater availability of injectable biologics, a rising preference for treatment at home, the expansion of specialty pharmaceuticals, and enhancements in the ergonomic design of injection devices.
The self-injections market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $15.05 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period can be attributed to several factors, including an escalating demand for self-care therapies, the increasing adoption of digital health-enabled injectors, the expansion of biologics pipelines, a heightened focus on adherence-enhancing drug delivery, and the growing use of connected medical devices. Prominent trends anticipated in this period encompass the increasing integration of auto-injector devices, a rising demand for wearable injection systems, the growing utilization of biologic self-administered therapies, the development of patient-centric drug delivery designs, and an enhanced emphasis on safety and dose accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Self-Injections Market Demand Drivers: What’s Powering Industry Growth?
The increasing count of diabetic patients is anticipated to propel the expansion of the self-injections market in the future. Diabetes describes a condition where the pancreas, the human organ producing insulin, generates an inadequate amount of insulin, which results in the breakdown of blood sugars and contributes to serious health issues like heart disease, vision loss, and kidney problems. Self-injections empower diabetic patients to administer insulin and other medicines, thereby helping to sustain optimal blood sugar levels and prevent any surplus blood sugars at any time without needing a medical professional. For instance, in November 2025, according to Diabetes Care, a US-based international peer-reviewed medical journal, an estimated 634.8 million adults, representing 12.0 percent of the global adult population, were living with impaired glucose tolerance in 2024, with this figure projected to climb to 846.5 million adults or 12.9 percent of the world’s adult population by 2050. Therefore, the rising number of diabetic patients is stimulating the growth of the self-injections market.
Self-Injections Market Segment Landscape: Which Areas Lead Development?
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Dosage: Single Dose, Multi Dose
3) By Application: Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Pain Management, Other Applications
4) By Distribution Channel: Chemist, Online Pharmacies
Subsegments:
1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors
2) By Formulations: Biologics, Small Molecules, Combination Products
Self-Injections Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the self-injections market are concentrating on innovations in drug delivery, such as hands-free, hidden-needle subcutaneous delivery, to simplify patients’ self-administration of large-volume biologics. This hands-free, hidden-needle subcutaneous delivery refers to a wearable injector that discretely delivers medication without manual operation, while keeping the needle concealed for enhanced comfort and safety. For instance, in November 2023, Enable Injections Inc., a US-based drug-delivery technology firm, obtained its first US Food and Drug Administration (FDA) approval for the enFuse large-volume wearable injector, to be used with EMPAVELI (pegcetacoplan). This compact, mechanical, body-worn device delivers up to 25 mL subcutaneously, allowing for self-administration or in-clinic administration with features like hands-free operation and reduced disruption to patients’ daily activities. The enFuse platform improves convenience, supports home-based care, and enhances the overall patient experience for large-volume therapy delivery.
Self-Injections Market Competitive Overview And Top Companies
Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.
View The Full Self-Injections Market Report:
Self-Injections Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the self-injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
